Prix Shanghai INT Medical Instruments Co., Ltd. (01501.HK)

Shanghai INT Medical Instruments Co., Ltd. engages in the research and development, manufacturing, and sales of interventional and implantable medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 2,007 full-time employees. The company went IPO on 2019-11-08. The firm operates its businesses through two segments. The Intracardiac Interventional Business segment is mainly engaged in the sales, manufacturing and research and development of intracardiac interventional medical devices and related molds, standard parts and masks. The Other segment is engaged in the research and development of other interventional medical devices, such as neurointerventional medical devices and heart valve implantable medical devices. The firm mainly operates its businesses in the domestic market and overseas markets.